4//SEC Filing
Aunins John G. 4
Accession 0000899243-20-002418
CIK 0001609809other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:05 PM ET
Size
5.5 KB
Accession
0000899243-20-002418
Insider Transaction Report
Form 4
Aunins John G.
CTO and EVP of Bioprocess Dev.
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2020-01-29+300,000→ 300,000 totalExercise: $3.30Exp: 2030-01-28→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on January 29, 2021. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001643756
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:05 PM ET
- Size
- 5.5 KB